NL-OMON30494撤回不适用
ADAMTS-13 levels in patients with a history of thrombotic thrombocytopenic purpura - ADAMTS-13 levels in TTP patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with a history of thrombotic thrombocytopenic purpura. Patients are approached by the patient association.
排除标准
- 未提供
研究者
相似试验
撤回
不适用
ADAMTS-13 levels in patients with a history of thrombotic thrombocytopenic purpura.thrombotische thrombocytopenic purpura10018849NL-OMON29947Academisch Medisch Centrum50
暂停
1 期
TAS0313 Phase I/II studySolid tumor (urothelial carcinoma, and so on)JPRN-jRCT2080223768Taiho Pharmaceutical Co., Ltd.130
招募中
不适用
ATTR amyloidosis in patients undergoing transcatheter aortic valve replacement: from prevalence to hemodynamic consequence.AmyloidosisNL-OMON55157niversitair Medisch Centrum Groningen340
Unknown
不适用
Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)Thrombotic MicroangiopathiesNCT02373267University of Cologne100
进行中（未招募）
1 期
Study in Patients with Primary Aldosteronism to Evaluate the Efficacy, Safety and Tolerability of the Aldosterone Synthase Inhibitor, DP13, over an 8-week Treatment PeriodPrimary AldosteronismEUCTR2019-000919-85-ITDAMIAN Pharma AG36